Exchange: NASDAQ·Updated 07:30 PM EDT
VRDN logo

VRDN Viridian Therapeutics Inc

$22.92
$0.04
(0.17%)
Today
Closed $22.92
$0.12
(0.52%)
After Hours
EarningsNov 5
Mkt Cap$2.6B
Vol759,916.00

About VRDN

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
44

Bearish Sentiment

How do you feel about VRDN?

Advertisement|Remove ads.